|
Dr. Weiser has served on the Board of Directors since its inception. Dr. Weiser is founder and co-chairman of Actin Capital LLC and Actin Biomed, a New York based healthcare investment group. Prior to joining Actin Dr. Weiser was the Director of Research at Paramount Capital Asset Management, Inc., New York. Dr. Weiser completed his Ph.D. in Molecular Neurobiology at Cornell University Medical College and received his M.D. from New York University School of Medicine, where he also completed a Postdoctoral Fellowship in the Department of Physiology and Neuroscience. In addition to serving on Chelsea’s Board, Dr. Weiser currently serves on the board of directors of Manhattan Pharmaceuticals, Inc, Emisphere Technologies, Inc., Ziopharm Oncology, Inc., Vioquest Pharmaceuticals, Inc. and Paramount Acquisition Corp. as well as several privately held companies. | 